HelixBind is a pioneering company based in Marlborough, MA, that is revolutionizing care for bloodstream infections through their innovative diagnostic platform. Their proprietary technology delivers faster, more accurate, and more informative microbiology results, enabling clinicians to precisely identify invasive infections and develop personalized antimicrobial interventions for infected patients.
With the aim of reducing the spread of antimicrobial resistance, improving outcomes, and saving lives, HelixBind's rapid and accurate identification of infections in just 4 hours, compared to the traditional blood culture test that takes 2-3 days, allows physicians to initiate appropriate antimicrobial treatment much earlier, significantly impacting patient prognosis and survival rates.
Generated from the website